Sermorelin is a synthetic research peptide modeled after a portion of growth hormone-releasing hormone (GHRH), the natural hormone that signals the pituitary gland to release growth hormone. This makes it useful for studying how the body’s own growth hormone signaling system is regulated.

Research has explored Sermorelin in connection with pituitary activity, growth hormone release, IGF-1 signaling, and endocrine function. Scientists use these pathways to investigate the relationship between hormonal signaling, metabolism, growth, and other biological processes.

Ophir Health Sermorelin provides a precisely measured format for laboratory research involving GHRH activity, pituitary signaling, growth hormone pathways, and endocrine biology.